Probiotics for women's health

Journal of Clinical Gastroenterology

Volumn 40, Issue 3, 2006, Pages 256-259

  Onderdonk, Andrew B ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CHANNING LABORATORY   (United States)

Author keywords

Bacterial vaginosis; Continuous culture; Preterm birth; Probiotic

Indexed keywords

PROBIOTIC AGENT; UNCLASSIFIED DRUG; VSL 3;

BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIUM CULTURE; CONFERENCE PAPER; CONTINUOUS CULTURE; CONTROLLED STUDY; FEASIBILITY STUDY; FERMENTATION; GARDNERELLA VAGINALIS; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; SIMULATION; VAGINA FLORA; WOMEN'S HEALTH;

CULTURE TECHNIQUES; FEMALE; GARDNERELLA VAGINALIS; HUMANS; PROBIOTICS; VAGINOSIS, BACTERIAL; WOMEN'S HEALTH;

EID: 33748166462     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200603000-00018     Document Type: Conference Paper

References (48)

1. Flynn CA, Helwig AL, Meurer LN. Bacterial vaginosis in pregnancy and the risk of prematurity: a meta-analysis [see comments]. J Fam Pract. 1999;48:885-892.
2. Foulon W, Van Liedekerke D, Demanet C, et al. Markers of infection and their relationship to preterm delivery. Am J Perinatol. 1995;12:208-211.
3. Friese K. The role of infection in preterm labour. Bjog 2003;110(Suppl 20):52-54.
4. Hay PE, Lamont RF, Taylor-Robinson D, et al. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage [see comments]. BMJ. 1994;308:295-298.
5. Hill GB. Preterm birth: associations with genital and possibly oral microflora. Ann Periodontol. 1998;3:222-232.
6. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group [see comments]. N Engl J Med. 1995;333:1737-1742.
7. Kimberlin DF, Andrews WW. Bacterial vaginosis: association with adverse pregnancy outcome. Semin Perinatol. 1998;22:242-250.
8. Klebanoff MA, Regan JA, Rao AV, et al. Outcome of the Vaginal Infections and Prematurity Study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci. Am J Obstet Gynecol. 1995;172:1540-1545.
9. Kurki T, Sivonen A, Renkonen OV, et al. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol. 1992;80:173-137.
10. Abele-Horn M, Peters J, Genzel-Boroviczeny O, et al. Vaginal Ureaplasma urealyticum colonization: influence on pregnancy outcome and neonatal morbidity. Infection. 1997;25:286-291.
11. Alger LS, Lovchik JC, Hebel JR, et al. The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome. Am J Obstet Gynecol. 1988;159:397-404.
12. Andrews WW, Goldenberg RL, Mercer B, et al. The Preterm Prediction Study: association of second-trimester genitourinary chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol. 2000;183:662-668.
13. Jonsson B, Rylander M, Faxelius G. Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates. Acta Paediatr. 1998;87:1079-1084.
14. Joste NE, Kundsin RB, Genest DR. Histology and Ureaplasma urealyticum culture in 63 cases of first trimester abortion. Am J Clin Pathol. 1994;102:729-732.
15. Krohn MA, Hillier SL, Lee ML, et al. Vaginal bacteroides species are associated with an increased rate of preterm delivery among women in preterm labor. J Infect Dis. 1991;164:88-93.
16. Krohn MA, Thwin SS, Rabe LK, et al. Vaginal colonization by Escherichia coli as a risk factor for very low birth weight delivery and other perinatal complications. J Infect Dis. 1997;175:606-610.
17. Lamont RF, Taylor-Robinson D, Wigglesworth JS, et al. The role of mycoplasmas, ureaplasmas and chlamydiae in the genital tract of women presenting in spontaneous early preterm labour. J Med Microbiol. 1987;24:253-257.
18. Martius J, Krohn MA, Hillier SL, et al. Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol. 1988;71:89-95.
19. Papiernik E. Preterm labor, preterm delivery, intrauterine infection, and preterm rupture of membranes. Curr Opin Obstet Gynecol. 1990;2:8-12.
20. Sweet RL, Landers DV, Walker C, et al. Chlamydia trachomatis infection and pregnancy outcome. Am J Obstet Gynecol. 1987;156:824-833.
21. Bejar R, Curbelo V, Davis C, et al. Premature labor. II. Bacterial sources of phospholipase. Obstet Gynecol. 1981;57:479-482.
22. Bennett PR, Rose MP, Myatt L, et al. Preterm labor: stimulation of arachidonic acid metabolism in human amnion cells by bacterial products. Am J Obstet Gynecol. 1987;156:649-655.
23. Bulkacz J, Erbland JF, MacGregor J. Phospholipase A activity in supernatants from cultures of Bacteroides melaninogenicus. Biochim Biophys Acta. 1981;664:148-155.
24. Bulkacz J, Schuster GS, Singh B, et al. Phospholipase A activity of extracellular products from Bacteroides melaninogenicus on epithelium tissue cultures. J Periodontal Res. 1985;20:146-153.
25. McGregor JA, French JI, Jones W, et al. Association of cervicovaginal infections with increased vaginal fluid phospholipase A2 activity. Am J Obstet Gynecol. 1992;167:1588-1594.
26. McGregor JA, Lawellin D, Franco-Buff A, et al. Phospholipase C activity in microorganisms associated with reproductive tract infection. Am J Obstet Gynecol. 1991;164:682-686.
27. Sandholm L, Mahlberg K, Jousimies-Somer H. Phospholipase A2: a possible virulence factor of Capnocytophaga ochracea. Oral Microbiol Immunol. 1988;3:18-21.
28. Onderdonk AB, Lee ML, Lieberman E, e al. Quantitative microbiologic models for preterm delivery. J Clin Microbiol. 2003;41:1073-1079.
29. Onderdonk AB, Polk BF, Moon NE, et al. Methods for quantitative vaginal flora studies. Am J Obstet Gynecol. 1977;128:777-781.
30. Lee M-LT, Ross RA, Onderdonk AB. Cluster analysis of vaginal microflora data. Microecol Ther. 1995;25:324-328.
31. Onderdonk AB, Zamarchi GR, Rodriguez ML. Quantitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol. 1987;53:2774-2778.
32. Onderdonk AB, Zamarchi GR, Walsh JA, et al. Methods for quantitative and qualitative evaluation of vaginal microflora during menstruation. Appl Environ Microbiol. 1986;51:333-339.
33. Ross RA, Lee ML, Delaney ML, et al. Mixed-effect models for predicting microbial interactions in the vaginal ecosystem. J Clin Microbiol. 1994;32:871-875.
34. Antsaklis A, Daskalakis G, Michalas S, et al. Erythromycin treatment for subclinical Ureaplasma urealyticum infection in preterm labor. Fetal Diagn Ther. 1997;12:89-92.
35. Ernest JM, Givner LB. A prospective, randomized, placebo-controlled trial of penicillin in preterm premature rupture of membranes [see comments]. Am J Obstet Gynecol. 1994;170:516-521.
36. Hauth JC, Goldenberg RL, Andrews WW, et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med. 1995;333:1732-1736.
37. Joesoef MR, Hillier SL, Wiknjosastro G, et al. Intravaginal clindamycin treatment for bacterial vaginosis: effects on preterm delivery and low birth weight. Am J Obstet Gynecol. 1995;173:1527-1531.
38. Morales WJ, Angel JL, O'Brien WF, et al. A randomized study of antibiotic therapy in idiopathic preterm labor. Obstet Gynecol. 1988;72:829-833.
39. Owen J, Groome LJ, Hauth JC. Randomized trial of prophylactic antibiotic therapy after preterm amnion rupture. Am J Obstet Gynecol. 1993;169:976-981.
40. Hay PE. Bacterial vaginosis and miscarriage. Curr Opin Infect Dis 2004;17:41-44.
41. Nishijima K, Shukunami K, Kotsuji F. Probiotics affects vaginal flora in pregnant women, suggesting the possibility of preventing preterm labor. J Clin Gastroenterol. 2005;39:447-448.
42. 2-generating Lactobacillus species for probiotic use. Curr Microbiol. 1999;38:279-284.
43. Reid G. Probiotics for urogenital health. Nutr Clin Care. 2002;5:3-8.
44. Reid G, Burton J, Devillard E. The rationale for probiotics in female urogenital healthcare. Med Gen Med. 2004;6:49.
45. Ross RA, Lee ML, Delaney M, et al. Use of continuous culture growth systems for modeling vaginal microflora behavior. Microecol Ther. 1995;23:16-17.
46. Geshnizgani AM, Onderdonk AB. Defined medium simulating genital tract secretions for growth of vaginal microflora. J Clin Microbiol. 1992;30:1323-1326.
47. Ross RA, Delaney ML, Onderdonk AB. Candida albicans in an in vitro model of the vaginal ecosystem. Microecol Ther. 1995;25:320-323.
48. Ross RA, Lee ML, Onderdonk AB. Effect of Candida albicans infection and clotrimazole treatment on vaginal microflora in vitro. Obstet Gynecol. 1995;86:925-930.